A bipartisan group of U.S. senators re-introduced a bill on Tuesday aimed at helping generic drug companies bring out a cheaper version of pharmaceuticals.
Makers of branded drugs have long been accused of refusing to provide samples of drugs on a government list of restricted medicines. Without the samples, generic competitors cannot prove their medicines are as safe and effective as the more expensive versions.
To combat this, Republican Senators Chuck Grassley and Mike Lee and Democrat Amy Klobuchar and some two dozen other senators from both sides of the aisle introduced a bill that spells out a legal pathway for generic companies to press for the samples.
In the U.S. House of Representatives, Rep. David Cicilline, a Democrat, and Jim Sensenbrenner, a Republican, and others introduced an identical measure.
The bill is one of several aimed at bringing down, or at least containing, the high and rising price of many medicines. It was considered in the previous Congress but failed to become law.
Was this article valuable?
Here are more articles you may enjoy.
American Family to Acquire Bowhead Specialty in $1.2B Cash Deal 
CBIZ Brokerage to Be Spun Off, Backed by Private Equity, After $5B Grant Thornton Deal 
Why El Niño’s Promise of Quieter Hurricane Season May Not Be Good News for Insurers 
AI Finding Twice as Many Cyber Flaws in 2026 as It Did in 2025 
